Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Lung Neoplasms 6Mesothelioma, Malignant 3Uterine Cervical Neoplasms 2Mesothelioma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Ovarian Neoplasms 1Gestational Trophoblastic Disease 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Ovarian Epithelial 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Ifosfamide 19Doxorubicin 19Filgrastim 17Radiotherapy 13Vincristine 11Cyclophosphamide 11Etoposide 9Cisplatin 9Granulocyte Colony-Stimulating Factor 8Gene Expression Profiling 8Trabectedin 7Polymerase Chain Reaction 7Dactinomycin 6sargramostim 5etoposide phosphate 5Paclitaxel 5Mesna 5Chemotherapy, Adjuvant 4Brachytherapy 4pegfilgrastim 3Topotecan 3Microarray Analysis 3Irinotecan 3Immunohistochemistry 3Imatinib Mesylate 3Gemcitabine 3Dexrazoxane 3Base Sequence 3olaparib 2brostallicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma × Pemetrexed × Clear all
NCT00107419 2012-01-18

S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma

SWOG Cancer Research Network

Phase 2 Completed
75 enrolled
Sarcoma

Chondrosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡